Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 16/9/2019
SIETES contiene 92806 citas

 
 
 1 a 7 de 7 
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Chen EY, Marcantonio A, Tornetta P 3rd. Correlation between 24-hour predischarge opioid use and amount of opioids prescribed at hospital discharge. JAMA Surgery 2017:13 de diciembre. [Ref.ID 102189]
2. Cita con resumen
Gutiérrez-Valencia M, Martínez-Velilla N, Vetrano DL, Corsonello A, Lattanzio F, Ladrón-Arana S, Onder G. Anticholinergic burden and health outcomes among older adults discharged from hospital: results from the CRIME study. Eur J Clin Pharmacol 2017;73:1467-74. [Ref.ID 102125]
3. Cita con resumen
Kanaan AO, Donovan JL, Duchin NP, Fields TS, Tija J, Cutrona SL, Gagne SJ, Garber L, Preusse P, Harrold LR, Gurwitz JH. Adverse drug events after hospitals discharge in older adults: types, severity, and involvement of beers criteria medications. J Am Geriatr Soc 2013;61:1894-9. [Ref.ID 96688]
4. Cita con resumen
Kripalani S, Roumie CL, Dalal AK, Cawthon C, Businger A, Eden SK, Shintani A, Sponsler KC, Harris LJ, Theobald C, Huang RL, Scheurer D, Hunt S, Jacobson TA, Rask KJ, Vaccarino V, Gandhi TK, Bates DW, Williams MV, Schnipper JL, and for the PILL-CVD (Pharmacist Intervention for Low Literacy in Cardiovascular Disease) Study Group. Effect of a pharmacist intervention on clinically important medication errors after hospital discharge: a randomized trial. Ann Intern Med 2012;157:1-10. [Ref.ID 93384]
5.
Thompson BT. ß-agonists for ARDS: the dark side of adrenergic stimulation?. Lancet 2012;379:196-8. [Ref.ID 92133]
6. Cita con resumen
Smith FG, Perkins GD, Gates S, Young D, McAuley DF, Tunnicliffe W, Khan Z, Lamb SE, for the BALTI-2 study investigators. Effect of intravenous ß-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial. Lancet 2012;379:229-35. [Ref.ID 92132]
7. Cita con resumen
Anónimo. Reacciones adversas a medicamentos registradas en el Conjunto Mínimo Básico de Datos (CMBD). Boletín de Farmacovigilancia de la Región de Murcia 2011;23:1-2. [Ref.ID 92092]
Seleccionar todas
 
 1 a 7 de 7